دورية أكاديمية
Re-centauring T cell antigen discovery around CD4 + T cells.
العنوان: | Re-centauring T cell antigen discovery around CD4 + T cells. |
---|---|
المؤلفون: | Smith BE; Program in Immunology, Harvard Medical School, Boston, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Chan AO; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Birnbaum ME; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: mbirnb@mit.edu. |
المصدر: | Cell reports methods [Cell Rep Methods] 2024 Jan 22; Vol. 4 (1), pp. 100694. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: Print Cited Medium: Internet ISSN: 2667-2375 (Electronic) Linking ISSN: 26672375 NLM ISO Abbreviation: Cell Rep Methods Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [New York] : Elsevier Inc., [2021]- |
مواضيع طبية MeSH: | T-Lymphocytes* , Autoimmunity*, Epitopes, T-Lymphocyte ; CD4-Positive T-Lymphocytes |
مستخلص: | In a recent issue of Cell, Dezfulian et al. develop a genome-scale platform to enable high-throughput identification of CD4 + T cell epitopes. This platform enables unbiased screens to discover antigens recognized by CD4 + T cells in cancer, infectious diseases, and autoimmunity. Competing Interests: Declaration of interests The authors declare no competing interests. (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.) |
التعليقات: | Comment in: Cell. 2023 Dec 7;186(25):5569-5586.e21. (PMID: 38016469) |
References: | J Clin Invest. 2019 Jan 2;129(1):324-335. (PMID: 30530988) Annu Rev Immunol. 2015;33:169-200. (PMID: 25493333) Nat Methods. 2021 Aug;18(8):873-880. (PMID: 32632239) Nat Immunol. 2005 May;6(5):490-6. (PMID: 15821740) JCI Insight. 2016 Jun 2;1(8):. (PMID: 27358913) Cell. 2023 Dec 7;186(25):5569-5586.e21. (PMID: 38016469) Cell. 2019 Aug 8;178(4):1016-1028.e13. (PMID: 31398327) Nat Rev Immunol. 2022 Dec;22(12):751-764. (PMID: 35418563) J Clin Invest. 2016 Jun 1;126(6):2093-108. (PMID: 27111229) |
معلومات مُعتمدة: | T32 GM144273 United States GM NIGMS NIH HHS |
المشرفين على المادة: | 0 (Epitopes, T-Lymphocyte) |
تواريخ الأحداث: | Date Created: 20240123 Date Completed: 20240125 Latest Revision: 20240425 |
رمز التحديث: | 20240425 |
مُعرف محوري في PubMed: | PMC10832272 |
DOI: | 10.1016/j.crmeth.2023.100694 |
PMID: | 38262348 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2667-2375 |
---|---|
DOI: | 10.1016/j.crmeth.2023.100694 |